Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
Article
in English
| IMSEAR
| ID: sea-85499
ABSTRACT
Gemfibrozil, a lipid lowering agent, was administered to two patients with familial hyperlipidaemia and one patient with insulin dependent diabetes mellitus. It was partially effective in familial hyperlipidaemia. It dramatically reduced triglyceride and cholesterol levels in the patient with Type V hyperlipidaemia and insulin dependent diabetes mellitus. Patients with familial and Type V hyperlipidaemias should be given a trial of gemfibrozil therapy.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Vascular Diseases
/
Female
/
Humans
/
Gemfibrozil
/
Adult
/
Hyperlipidemias
/
Hyperlipidemia, Familial Combined
/
Cholesterol, HDL
/
Cholesterol, LDL
Language:
English
Year:
1990
Type:
Article
Similar
MEDLINE
...
LILACS
LIS